Elsevier

Journal of Hepatology

Volume 52, Issue 6, June 2010, Pages 880-888
Journal of Hepatology

Research Article
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study

https://doi.org/10.1016/j.jhep.2009.12.037Get rights and content

Background & Aims

Hepatocellular carcinoma (HCC) prognosis strongly depends upon nuclear grade and the presence of microscopic vascular invasion (MVI). The aim of this study was to develop an artificial neural network (ANN) that is able to predict tumour grade and MVI on the basis of non-invasive variables.

Methods

Clinical, radiological, and histological data from 250 cirrhotic patients resected (n = 200) or transplanted (n = 50) for HCC were analyzed. ANN and logistic regression models were built on a training group of 175 randomly chosen patients and tested on the remaining testing group of 75. Receiver operating characteristics curve (ROC) and k-statistics were used to analyze model accuracy in the prediction of the final histological assessment of tumour grade (G1–G2 vs. G3–G4) and MVI (absent vs. present).

Results

Pathologic examination showed G3–G4 in 69.6% of cases and MVI in 74.4%. Preoperative serum alpha-fetoprotein (AFP), tumour number, size, and volume were related to tumour grade and MVI (p <0.05) and were used for ANN building, whereas, tumour number did not enter into the logistic models. In the training group, ANN area under ROC curves (AUC) for tumour grade and MVI prediction were 0.94 and 0.92, both higher (p <0.001) than those of logistic models (0.85 for both). In the testing group, ANN correctly identified 93.3% of tumour grades (k = 0.81) and 91% of MVI (k = 0.73). Logistic models correctly identified 81% of tumour grades (k = 0.55) and 85% of MVI (k = 0.57).

Conclusion

ANN identifies HCC tumour grades and MVI on the basis of preoperative variables more accurately than the conventional linear model and should be used for tailoring clinical management.

Introduction

Hepatocellular carcinoma (HCC) is one of the five most common malignancies worldwide and often occurs in patients with chronic viral hepatitis and cirrhosis [1]. Although current screening techniques identify approximately one third of the tumours at a potentially curable stage, the high incidence of recurrence, both after surgical and non-surgical approaches, remains a major challenge in HCC management [2], [3], [4], [5]. Tumour histological features strongly influence not only tumour recurrence but also patient survival: nuclear grading and vascular invasion are considered the two most important prognostic factors but they are accurately assessable only with the pathological examination of surgical specimens. Furthermore, only a minority of cirrhotic patients with HCC are eligible for resection or transplantation [3], [4], [5], [6], [7], [8], [9], [10]. Percutaneous fine-needle aspiration (FNA) biopsy can be used to characterize HCC grade but its usefulness remains controversial as the heterogeneity of the histological grade, within a single tumour, may limit overall accuracy [11]; in addition, FNA cannot assess microscopic vascular invasion (MVI). Several authors have investigated the relationship between morphological characteristics of the tumour, its grade, and the presence of MVI. Tumour size and number of lesions, assessed on surgical pathologic specimens, as well as serum alpha-fetoprotein (AFP) are the variables that were most frequently found to be associated with both tumour grade and vascular invasion; given the strict relationship reported between tumour grade and microscopic vascular invasion, histological grade is currently used as a surrogate marker of MVI [11], [12], [13], [14], [15]. However, the interaction among these factors is complex and non-linear [5], [13], [16], thus, making it difficult to distinguish between classes when using the conventional linear discriminant analysis. When classes are separated by a non-linear boundary, as in the present situation, an artificial neural network (ANN) has been demonstrated to perform better than conventional discriminant analysis [17], [18], [19], [20].

The artificial neural network uses computer technology to model a biological neural system both structurally and functionally. Like its biological counterpart, an artificial neural network consists of a set of highly interconnected processing units (neurons) tied together with weighted connections. The network itself consists of an input layer, an output layer, and one or more hidden layers. The input layer comprises the data available for the analysis (e.g. various laboratory tests) and the output layer comprises the outcome (e.g. diagnosis). One of the basic characteristics of the ANN is that it learns through examples: learning is achieved through exposure of paired input–output data (training). An ANN learns to associate each input with the corresponding output, by modifying the weight of the connections between neurons. Once an input has been applied as a stimulus to the first layer of neurons it is propagated through each upper layer until an output is generated. This output pattern is then compared to the desired output and an error signal is generated: the error signal is then transmitted backwards across the net and the connection weight between neurons is updated in order to decrease the overall error of the network. As learning proceeds, the error between ANN output and the desired output decreases until a minimum is reached. Based on the knowledge accumulated during training, the ANN can assign outputs (diagnoses) to new input data not used in the learning process. Thus, after training, the ANN can identify patterns or make predictions on datasets never seen before [17], [18], [19], [20], [21].

The main aim of the present study was to assess the ability of the ANN to predict tumour grade on the basis of preoperative clinical and radiological variables. We also explored its ability to predict MVI and compared ANN performance to that of a conventional logistic regression model.

Section snippets

Patients and methods

Between January 1999 and December 2008, 469 patients with HCC in cirrhosis underwent surgery at the Department of Surgery and Transplantation at the University of Bologna. Of these patients, 246 were subjected to hepatic resection and 223 received a liver transplantation. The policy in our center regarding indications for hepatic resection and liver transplantation have been described elsewhere [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22]. In particular, in

Results

Baseline characteristics of the entire study population are outlined in Table 1 and tumour characteristics detailed in Fig. 2. Mean age was 62.8 ± 9.9 years (range: 32–85) and patients were predominantly male (77.2%). Pathologic examination showed well-differentiated tumours in 76 patients (30.4%), moderately differentiated tumours in 150 (60.0%), and poorly differentiated tumours in 24 (9.6%). MVI was observed in 186 cases (74.4%) and was closely related to tumour grade (p <0.001 at Pearson

Discussion

Tumour grading and microscopic vascular invasion are accepted worldwide as the two most powerful predictors of prognosis in patients with HCC both after hepatic resection and transplantation, as shown by many series investigating these topics [3], [4], [5], [6], [7], [8], [9]. Utilization of these features prior to treatment are therefore, highly desired, as they could help surgeons and clinicians in providing optimal management of HCC patients [30]. Attempts have been made in the past to

Conflicts of interest

The Authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

Acknowledgments

Authors thank Andrea Valgimigli for website construction, Dott. Marco Vivarelli, Dott. Giorgio Ercolani and Marian Shields for help with manuscript.

References (39)

  • H.B. El-Serag et al.

    The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

    Ann Intern Med

    (2003)
  • C.J. Thompson et al.

    Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

    Health Technol Assess

    (2007)
  • J.D. Wayne et al.

    Preoperative predictors of survival after resection of small hepatocellular carcinomas

    Ann Surg

    (2002)
  • J.M. Regimbeau et al.

    Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study

    J Surg Oncol

    (2004)
  • G.B. Klintmalm

    Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumour characteristics on outcome

    Ann Surg

    (1998)
  • R.T. Poon et al.

    Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

    Cancer

    (2000)
  • N. Portolani et al.

    Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications

    Ann Surg

    (2006)
  • A. Cucchetti et al.

    Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population

    Ann Surg Oncol

    (2009)
  • L. Bolondi et al.

    Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

    Gut

    (2001)
  • Cited by (168)

    View all citing articles on Scopus
    View full text